Esophageal catheter market seen growing to $3.91 billion by 2030

The Business Research Company says the global esophageal catheters market will rise from $2.62 billion in 2025 to $2.82 billion in 2026, then reach $3.91 billion by 2030. The report points to rising gastrointestinal disease, more outpatient diagnostics and wider use of minimally invasive procedures as the main growth drivers.

Why it matters: - The market is expanding as hospitals and clinics need more tools to diagnose and treat esophageal disorders. - Rising cases of GERD, dysphagia and esophageal cancer are increasing demand for precise pressure monitoring and motility testing. - Growth in outpatient care and minimally invasive procedures is pushing adoption of newer catheter designs. - The shift matters for device makers, gastroenterology departments and healthcare systems facing more digestive disease cases.

What happened: - The Business Research Company published an esophageal catheters market report covering market size, trends and forecasts through 2035. - The report estimates the market will grow from $2.62 billion in 2025 to $2.82 billion in 2026. - The same report projects the market will reach $3.91 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - The report says the market is growing at a 7.6% compound annual growth rate in 2026. - The forecast through 2030 implies an 8.5% CAGR. - Historic growth has been supported by more gastrointestinal diagnoses, more frequent GERD and dysphagia testing, expansion of gastroenterology departments and wider use of advanced catheter designs. - Esophageal catheters are specialized medical devices used for diagnostic and therapeutic applications involving the esophagus. - The devices are used to evaluate esophageal function and help diagnose disorders affecting the esophagus. - Chronic esophageal disorders are a major growth driver because they require accurate diagnosis and monitoring. - Manometry catheters measure pressure changes and motility patterns in the esophagus to support diagnosis and treatment planning. - The report highlights rising use of single-use esophageal catheters, higher demand for precise pressure monitoring, more minimally invasive diagnostic techniques and increased radiofrequency ablation procedures. - The report also cites a stronger focus on patient comfort and safety. - A January 2023 National Library of Medicine report estimates about 739,666 new esophageal cancer cases and 723,466 deaths in the United States by 2030. - The same report projects 987,723 global cases and 914,304 global deaths by 2040. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The forecast suggests demand is shifting from broad diagnostic use toward more specialized, data-driven procedures. - Single-use devices and outpatient tools point to a market that is optimizing for speed, infection control and convenience. - The regional split suggests mature demand in North America and faster expansion in Asia-Pacific as healthcare access widens. - The cancer projections reinforce why better esophageal diagnostics could see sustained clinical demand.

What's next: - The report expects continued growth as outpatient diagnostics, precision testing and minimally invasive treatment adoption expand. - Investment in gastrointestinal healthcare and patient-centered care is expected to support further market gains. - Asia-Pacific is likely to capture more growth as healthcare services and awareness of gastrointestinal health expand.

The bottom line: - Esophageal catheters are moving from a niche diagnostic tool to a broader growth market tied to rising digestive disease and more advanced esophageal care.